Skip to main content
. 2022 Feb 10;2(2):78–89. doi: 10.1158/2767-9764.CRC-21-0146

TABLE 1.

Patient summary demographics.

Progressive disease
(nonresponders)
(n = 7)
Complete response
(responders)
(n = 7)
Sex (male/female) 7/0 5/2
Median age at time of biopsy (range) 60 (41–83) 53 (51–74)
Stage at time of biopsy
 Stage III 7 6
 Stage IV 0 1
Site of surgical excisional biopsy
 Lymph node 7 7
Days from diagnosis to ICI treatment 239 (12–657) 204 (11–734)
ICI therapy
 Single (anti-PD1) 4 4
 Combination (anti-PD1 with anti-CTLA4 or anti-IDO) 3 3
Median time to follow-up (months) 9.4 (1.1–29.6) 49.9 (25.5–80.5)